Global Antiandrogen Monotherapy Market Research Report 2016

Global Antiandrogen Monotherapy Market Research Report 2016

1 Antiandrogen Monotherapy Market Overview

1.1 Product Overview and Scope of Antiandrogen Monotherapy

1.2 Antiandrogen Monotherapy Segment by Type

1.2.1 Global Production Market Share of Antiandrogen Monotherapy by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 Antiandrogen Monotherapy Segment by Application

1.3.1 Antiandrogen Monotherapy Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Antiandrogen Monotherapy Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Antiandrogen Monotherapy (2011-2021)

2 Global Antiandrogen Monotherapy Market Competition by Manufacturers

2.1 Global Antiandrogen Monotherapy Production and Share by Manufacturers (2015 and 2016)

2.2 Global Antiandrogen Monotherapy Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Antiandrogen Monotherapy Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution, Sales Area and Product Type

2.5 Antiandrogen Monotherapy Market Competitive Situation and Trends

2.5.1 Antiandrogen Monotherapy Market Concentration Rate

2.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Antiandrogen Monotherapy Production, Revenue (Value) by Region (2011-2016)

3.1 Global Antiandrogen Monotherapy Production and Market Share by Region (2011-2016)

3.2 Global Antiandrogen Monotherapy Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Antiandrogen Monotherapy Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Antiandrogen Monotherapy Consumption by Regions (2011-2016)

4.2 North America Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Antiandrogen Monotherapy Production, Revenue (Value), Price Trend by Type

5.1 Global Antiandrogen Monotherapy Production and Market Share by Type (2011-2016)

5.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)

5.3 Global Antiandrogen Monotherapy Price by Type (2011-2016)

5.4 Global Antiandrogen Monotherapy Production Growth by Type (2011-2016)

6 Global Antiandrogen Monotherapy Market Analysis by Application

6.1 Global Antiandrogen Monotherapy Consumption and Market Share by Application (2011-2016)

6.2 Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Antiandrogen Monotherapy Manufacturers Profiles/Analysis

7.1 Pfizer Inc. (USA)

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Abbott Laboratories (USA)

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Genentech Inc. (USA)

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 GlaxoSmithKline Plc (UK)

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Immunomedics, Inc. (USA)

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Indevus Pharmaceuticals Inc. (USA)

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Novartis AG (Switzerland)

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 OSI Pharmaceuticals, Inc. (USA)

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Paladin Labs Inc. (Canada)

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 ALZA Corporation (USA)

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Antiandrogen Monotherapy Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 ALZA Corporation (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Amgen Inc. (USA)

7.12 AstraZeneca PLC (UK)

7.13 Medimmune, LLC (USA)

7.14 Bristol-Myers Squibb Company (USA)

7.15 Cell Genesys Inc. (USA)

7.16 Dendreon Corporation (USA)

7.17 EUSA Pharma, (USA) Inc. (USA)

7.18 F. Hoffmann-La Roche Ltd. (Switzerland)

7.19 Progenics Pharmaceuticals, Inc. (USA)

7.20 Sanofi-Aventis SA (France)

7.21 Spectrum Pharmaceuticals, Inc. (USA)

7.22 Takeda Pharmaceutical Company Limited (Japan)

8 Antiandrogen Monotherapy Manufacturing Cost Analysis

8.1 Antiandrogen Monotherapy Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Antiandrogen Monotherapy Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Antiandrogen Monotherapy Market Forecast (2016-2021)

12.1 Global Antiandrogen Monotherapy Production, Revenue Forecast (2016-2021)

12.2 Global Antiandrogen Monotherapy Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Antiandrogen Monotherapy Production Forecast by Type (2016-2021)

12.4 Global Antiandrogen Monotherapy Consumption Forecast by Application (2016-2021)

12.5 Antiandrogen Monotherapy Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Antiandrogen Monotherapy

Figure Global Production Market Share of Antiandrogen Monotherapy by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Antiandrogen Monotherapy Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Antiandrogen Monotherapy Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Antiandrogen Monotherapy Production of Key Manufacturers (2015 and 2016)

Table Global Antiandrogen Monotherapy Production Share by Manufacturers (2015 and 2016)

Figure 2015 Antiandrogen Monotherapy Production Share by Manufacturers

Figure 2016 Antiandrogen Monotherapy Production Share by Manufacturers

Table Global Antiandrogen Monotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Antiandrogen Monotherapy Revenue Share by Manufacturers

Table 2016 Global Antiandrogen Monotherapy Revenue Share by Manufacturers

Table Global Market Antiandrogen Monotherapy Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Antiandrogen Monotherapy Average Price of Key Manufacturers in 2015

Table Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution and Sales Area

Table Manufacturers Antiandrogen Monotherapy Product Type

Figure Antiandrogen Monotherapy Market Share of Top 3 Manufacturers

Figure Antiandrogen Monotherapy Market Share of Top 5 Manufacturers

Table Global Antiandrogen Monotherapy Production by Regions (2011-2016)

Figure Global Antiandrogen Monotherapy Production and Market Share by Regions (2011-2016)

Figure Global Antiandrogen Monotherapy Production Market Share by Regions (2011-2016)

Figure 2015 Global Antiandrogen Monotherapy Production Market Share by Regions

Table Global Antiandrogen Monotherapy Revenue by Regions (2011-2016)

Table Global Antiandrogen Monotherapy Revenue Market Share by Regions (2011-2016)

Table 2015 Global Antiandrogen Monotherapy Revenue Market Share by Regions

Table Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Table China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Table India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Antiandrogen Monotherapy Consumption Market by Regions (2011-2016)

Table Global Antiandrogen Monotherapy Consumption Market Share by Regions (2011-2016)

Figure Global Antiandrogen Monotherapy Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Antiandrogen Monotherapy Consumption Market Share by Regions

Table North America Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)

Table Europe Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)

Table China Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)

Table Japan Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)

Table India Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)

Table Global Antiandrogen Monotherapy Production by Type (2011-2016)

Table Global Antiandrogen Monotherapy Production Share by Type (2011-2016)

Figure Production Market Share of Antiandrogen Monotherapy by Type (2011-2016)

Figure 2015 Production Market Share of Antiandrogen Monotherapy by Type

Table Global Antiandrogen Monotherapy Revenue by Type (2011-2016)

Table Global Antiandrogen Monotherapy Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Antiandrogen Monotherapy by Type (2011-2016)

Figure 2015 Revenue Market Share of Antiandrogen Monotherapy by Type

Table Global Antiandrogen Monotherapy Price by Type (2011-2016)

Figure Global Antiandrogen Monotherapy Production Growth by Type (2011-2016)

Table Global Antiandrogen Monotherapy Consumption by Application (2011-2016)

Table Global Antiandrogen Monotherapy Consumption Market Share by Application (2011-2016)

Figure Global Antiandrogen Monotherapy Consumption Market Share by Application in 2015

Table Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2011-2016)

Figure Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2011-2016)

Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (USA) Antiandrogen Monotherapy Market Share (2011-2016)

Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Market Share (2011-2016)

Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure Immunomedics, Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)

Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)

Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG (Switzerland) Antiandrogen Monotherapy Market Share (2011-2016)

Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)

Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Market Share (2011-2016)

Table ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ALZA Corporation (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

Figure ALZA Corporation (USA) Antiandrogen Monotherapy Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antiandrogen Monotherapy

Figure Manufacturing Process Analysis of Antiandrogen Monotherapy

Figure Antiandrogen Monotherapy Industrial Chain Analysis

Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015

Table Major Buyers of Antiandrogen Monotherapy

Table Distributors/Traders List

Figure Global Antiandrogen Monotherapy Production and Growth Rate Forecast (2016-2021)

Figure Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2016-2021)

Table Global Antiandrogen Monotherapy Production Forecast by Regions (2016-2021)

Table Global Antiandrogen Monotherapy Consumption Forecast by Regions (2016-2021)

Table Global Antiandrogen Monotherapy Production Forecast by Type (2016-2021)

Table Global Antiandrogen Monotherapy Consumption Forecast by Application (2016-2021)